在心脏病中使用抗血小板治疗
1Department of Cardiovascular Medicine, Ankara University School of Medicine, 06450 Ankara, Turkey.
Reviews in cardiovascular medicine
|July 9, 2025
概括
抗血小板治疗对于预防心脏病中的血栓至关重要,但平衡出血风险是关键. 目前的策略侧重于个性化,以患者为中心的方法,以获得最佳的结果.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 血栓形成的原因之一是血栓形成.
背景情况:
- 抗血小板治疗对于治疗动脉样硬化心血管疾病和预防血栓事件至关重要.
- 由于出血风险,其在初级预防中的作用有限,而二级预防有利于稳定的患者.
- 使用阿司匹林和P2Y12抑制剂的双抗血小板治疗 (DAPT) 改善了急性冠状动脉综合征的结果.
研究的目的:
- 审查心脏病中抗血小板治疗策略的演变.
- 要突出当前的做法,特殊的人口考虑,和后结构性心脏干预方案.
- 讨论针对抗血小板治疗量身定制的进展,以提高疗效和安全性.
主要方法:
- 对关键研究和当前抗血小板治疗指南的审查.
- 关于双疗法与单疗法以及不同P2Y12抑制剂的证据分析.
- 整合关于支架技术和患者特定风险概况的数据.
主要成果:
- 长期单一治疗有利于稳定的二次预防患者.
- 在急性冠状动脉综合征中,DAPT (阿司匹林+P2Y12抑制剂) 优于单独的阿司匹林,而普拉苏格勒和蒂卡格勒勒具有强大作用.
- 个体化风险评估至关重要,因为密集治疗方案会增加出血风险.
结论:
- 目前的指南强调个性化抗血小板治疗的持续时间和强度.
- 支架技术的进步和风险分析使得量身定制的战略成为可能.
- 新型药物和个性化方法正在塑造心血管疾病抗血小板治疗的以患者为中心的未来.
相关概念视频
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
652
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
652
01:27Coronary Artery Disease V: Interprofessional Care
38
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
38
01:27Peripheral Artery Disease III: Interprofessional Care
32
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
32
01:26Atherosclerosis III: Management
41
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
41
01:26Angina IV: Management
28
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
28
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
919
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
919